| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
37,357,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing therapies for rare endocrine disorders with unmet medical need. Co. is developing its wholly-owned product candidate, tildacerfont, as a non-steroidal therapy to provide improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia and polycystic ovary syndrome.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,838,400 |
| Total Buy Value |
$0 |
$0 |
$0 |
$8,997,728 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
4,172,336 |
4,172,336 |
4,172,336 |
4,172,336 |
| Total Sell Value |
$3,408,657 |
$3,408,657 |
$3,408,657 |
$3,408,657 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
5 |
5 |
5 |
5 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gharib Samir M. |
President & CFO |
• – – |
2022-06-30 |
4 |
D |
$1.74 |
$22,564 |
D/D |
(12,968) |
33,610 |
|
- |
|
| Gharib Samir M. |
President & CFO |
• – – |
2022-06-30 |
4 |
A |
$1.48 |
$8,055 |
D/D |
5,446 |
46,578 |
|
- |
|
| Gharib Samir M. |
President & CFO |
• – – |
2022-06-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,500 |
41,132 |
|
- |
|
| Gharib Samir M. |
President & CFO |
• – – |
2021-12-31 |
4 |
A |
$3.79 |
$8,416 |
D/D |
2,220 |
4,632 |
|
- |
|
| King Richard |
Chief Executive Officer |
• • – |
2021-06-30 |
4 |
A |
$9.53 |
$21,249 |
D/D |
2,230 |
2,230 |
|
- |
|
| Gharib Samir M. |
Chief Financial Officer |
• – – |
2021-06-30 |
4 |
A |
$9.53 |
$13,454 |
D/D |
1,412 |
1,412 |
|
- |
|
| Simpson Camilla V |
Director |
– • – |
2021-05-20 |
4 |
AS |
$15.29 |
$5,107 |
D/D |
(334) |
0 |
|
- |
|
| Simpson Camilla V |
Director |
– • – |
2021-05-20 |
4 |
OE |
$0.85 |
$284 |
D/D |
334 |
334 |
|
- |
|
| Novo A/s |
10% Owner |
– – • |
2021-05-19 |
4 |
S |
$13.90 |
$6,602,500 |
D/D |
(475,000) |
4,514,336 |
|
- |
|
| Simpson Camilla V |
Director |
– • – |
2021-04-30 |
4 |
AS |
$16.14 |
$226,664 |
D/D |
(14,045) |
0 |
|
- |
|
| Simpson Camilla V |
Director |
– • – |
2021-04-30 |
4 |
OE |
$0.85 |
$11,938 |
D/D |
14,045 |
14,045 |
|
- |
|
| Novo A/s |
10% Owner |
– – • |
2020-10-14 |
4 |
B |
$15.00 |
$3,750,000 |
D/D |
250,000 |
4,989,336 |
2.45 |
- |
|
| Novo A/s |
10% Owner |
– – • |
2020-10-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4,739,336 |
4,739,336 |
|
- |
|
| Rivervest Venture Fund Iv, L.p. |
10% Owner |
– – • |
2020-10-14 |
4 |
B |
$15.00 |
$3,750,000 |
I/I |
250,000 |
2,148,281 |
1.5 |
- |
|
| Rivervest Venture Fund Iv, L.p. |
10% Owner |
– – • |
2020-10-14 |
4 |
A |
$0.00 |
$0 |
I/I |
1,898,281 |
1,898,281 |
|
- |
|
| Healthcap Viii, L.p. |
Former 10% Owner |
– – – |
2020-10-14 |
4 |
B |
$15.00 |
$3,750,000 |
D/D |
250,000 |
2,033,621 |
2.44 |
- |
|
| Healthcap Viii, L.p. |
Former 10% Owner |
– – – |
2020-10-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,783,621 |
1,783,621 |
|
- |
|
| Odonnell Niall |
Director |
– • – |
2020-10-14 |
4 |
B |
$15.00 |
$3,750,000 |
I/I |
250,000 |
695,905 |
2.1 |
- |
|
| Odonnell Niall |
Director |
– • – |
2020-10-14 |
4 |
A |
$0.00 |
$0 |
I/I |
445,905 |
445,905 |
|
- |
|
| Chaya Moghrabi Dina |
Director |
– • – |
2020-10-14 |
4 |
B |
$15.00 |
$3,750,000 |
I/I |
250,000 |
2,161,022 |
2.1 |
- |
|
| Chaya Moghrabi Dina |
Director |
– • – |
2020-10-14 |
4 |
A |
$0.00 |
$0 |
I/I |
1,911,022 |
1,911,022 |
|
- |
|
| Hansson Jonas |
Director |
– • – |
2020-10-14 |
4 |
B |
$15.00 |
$3,750,000 |
I/I |
250,000 |
2,033,621 |
2.1 |
- |
|
| Hansson Jonas |
Director |
– • – |
2020-10-14 |
4 |
A |
$0.00 |
$0 |
I/I |
1,783,621 |
1,783,621 |
|
- |
|
| Muralidhar Bali |
Director |
– • – |
2020-10-14 |
4 |
B |
$15.00 |
$3,000,000 |
I/I |
200,000 |
1,792,518 |
2.1 |
- |
|
| Muralidhar Bali |
Director |
– • – |
2020-10-14 |
4 |
A |
$0.00 |
$0 |
I/I |
1,592,518 |
1,592,518 |
|
- |
|
52 Records found
|
|
Page 2 of 3 |
|
|
